Institut Curie: Uveal Melanoma trials
The registry lists 13 Uveal Melanoma studies with Institut Curie as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method StudyNot yet recruitingNCT06073548
- Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)RecruitingNCT04424719Not applicable
- Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)CompletedNCT05282901Phase 2
- Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)CompletedNCT04728113Not applicable
- Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)CompletedNCT04118062Not applicable
- Study of the Activity of PD-1 Inhibitors in Metastatic Uveal MelanomaCompletedNCT03964298
- Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)CompletedNCT02875652Not applicable
- Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)CompletedNCT02874040Not applicable
- Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)CompletedNCT02849145Not applicable
- Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal MelanomaCompletedNCT02843386Phase 3
- Study of Circulating Tumoral DNA in Metastatic Choroidal MelanomaCompletedNCT01334008Not applicable
- Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the EyeStatus unknownNCT01217398Phase 2
- Bone Marrow and Blood Samples From Patients With Metastatic Choroid MelanomaCompletedNCT00897624